Ascidian Therapeutics CEO Michael Ehlers is leaving the venture investor that serves as his home base and will join MPM ...
Summit Therapeutics and its Chinese partner Akeso have a few competitors now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback